Parkinsons Disease Drug Market
Parkinsons Disease Drug Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Parkinsons Disease Drug Market Size and Growth
The Parkinson's Disease drug market is experiencing significant growth, driven by increasing prevalence, advancements in therapies, and robust pipeline developments. The market size was estimated at approximately USD 4.5 billion in 2022 and is projected to reach USD 7.0 billion by 2030, reflecting a compound annual growth rate of around 6.0%.
Companies Covered
(Covid 19 Impact Covered)
◍ Teva
◍ Novartis AG
◍ GSK
◍ AbbVie
◍ Merck
◍ Boehringer Ingelheim
◍ Impax Laboratories
◍ Lundbeck
◍ Sun Pharma
◍ Wockhardt
◍ UCB
◍ Bausch Health
◍ Acadia
The Parkinson's Disease drug market features key players like Teva, Novartis, GSK, AbbVie, Merck, and others. These companies enhance the market through innovative therapies, advanced research, and strategic partnerships, driving growth. Notable sales include AbbVie's $56 billion, Teva's $16 billion, and Novartis' $49 billion in pharmaceutical revenue. Request Sample Report
Market Segmentation
By Application
Hospital
Clinics
Other
By Product
◍ Carbidopa/Levodopa
Dopamine Receptor Agonists
MAO-Inhibitors
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
